期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

活性维生素D_3及其受体对糖尿病肾病的影响 被引量：4

The Impacts of Active Vitamin D_3 and Its Receptor on Diabetic Nephropathy
下载PDF
导出
摘要 半个多世纪以来,活性维生素D3,即1,25-二羟维生素D3[1-25(OH)2D3]在糖尿病相关治疗研究中成为热点。由于1-25(OH)2D3及其特异性受体在糖尿病肾病中有一定抑制肾脏纤维化作用而备受关注。其可能通过参与抑制肾素-血管紧张素系统激活、减少纤维化因子释放及氧化应激等过程发挥作用,目前机制尚未完全明确。该文针对1-25(OH)2D3及其受体在肾脏中的表达及其相互作用进行阐述,以期为糖尿病的预防和诊治带来新的契机。 For more than half a century,the research of active vitamin D3（1,25-（OH） 2D3） has been the hot spot of diabetic nephropathy（DN） therapy.Active vitamin D3 and its specific receptors vitamin D receptor（VDR） play a protective role in renal fibrosis of DN.It may suppress the activation of renin-angiotensin system（RAS） system,reduce the release of fibrosis factors and the oxidative stress,though the underlying mechanism is still unclear.Here mainly expounds the positive effects and interaction of active vitamin D3 and VDR in the regulation of DN which may bring a new opportunity for the prevention and treatment of DN.
作者 张园园 朱筠
机构地区 新疆医科大学第一附属医院内分泌科
出处 《医学综述》 2015年第7期1257-1260,共4页 Medical Recapitulate
关键词 糖尿病肾病 活性维生素D3 维生素D受体 Diabetic nephropathy Active vitamin D3 Vitamin D receptor
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献30

  • 1De Luca HF.Vitamin D:the vitamin and the hormone[J].Fed Proc,1974,33(11):2211-2219.
  • 2Aubin JE,Bonnelye E.Osteoprotegerin and its ligand:a new paradigm for regulation of osteoclastogenesis and bone resorption[J].Osteoporosis Int,2000,11(11):905-913.
  • 3Plum LA,De Luca HF.Vitamin D,disease and therapeutic opportunities[J].Nat Rev Drug Discov,2010,9(12):941-955.
  • 4Fukumoto S.Physiological regulation and disorders of phosphate metabolism-pivotal role of fibroblast growth factor 23[J].Intern Med,2008,47(5):337-343.
  • 5Liao J,Kobayashi M,Kanamuru Y,et al.Eeffects of candesarton,an angiotensin II type 1 receptor blocker on diabetic nephropathy in KK/Ta mice[J].J Nephrol,2003,16(6):841-849.
  • 6Chagas CE,Borges MC,Martini LA,et al.Focus on vitamin D,inflammation and type 2 diabetes[J].Nutrients,2012,4(1):52-67.
  • 7Deb DK,Chen Y,Zhang Z,et al.1,25-Dihydroxyvitamin D3suppresses high glucose-induced angiotensingen expression in kidney cells by blocking the NF-k B pathway[J].Am J Physiol Renal Physiol,2009,296(5):1212-1218.
  • 8Forman JP,Williams JS,Fisher ND.Plasma 25-hydroxyvitamin D and regulation of the renin angiotensin system in humans[J].Hypertension,2010,55(5):1283-1288.
  • 9Dong J,Wong SL,Lau CW,et al.Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1receptors and reducing oxidative stress[J].Eur Heart J,2012,33(23):2980-2990.
  • 10Zhang Z,Zhang Y,Ning G,et al.Combination therapy with AT1blocker and vitamin D analog markedly ameliorates diabetic nephropathy:blockade of compensatory rennin increase[J].Proc Natl Acad Sci U S A,2008,105(41):15896-15901.

二级参考文献25

  • 1Ishimura T, Fujisawa M, Isotani S, et al. Transforming growth factor β1 expression in early biopsy specimen predicts long term graf fuction following pediatrlerenal transplantation [ J ]. Clin Trans plant,2001,15(3) :185- 191.
  • 2Border WA, Noble NA. TGF - β1 in kidney fibrosis: a target for gene therapy[J]. Kidney lnt, 1997,51(5) : 1388 - 1396.
  • 3Ishii H, Tada H, Isogai S. Analdose reductase inhibitor prevents glucose induced increase in transforming growth factor β and pro tein kinase eactivity incultured mesangial cells [ J ]. Diabtolongia, 1998,41(3) :362 - 364.
  • 4Ewan Sanders APG,Gedroye WG,Akutoubi MA, et al. The use of metalstents in transplant renal stenosis[ J ]. Clin Radiol, 1995,50: 245 - 250.
  • 5Orranine C, Racusen RT, Solezk P, et al. The Banff 97 working classification of renal allograft pathology[J ]. Kidney Int, 1999, 55:713 - 723.
  • 6Lemire JM, Archer DC, Beck L, et al. Immunosuppressive actions of 1,25 - dihydroxyvitamin D3 :preferential inhibition of Th1 functions[J]. J Nutr, 1995,125 : 1704.
  • 7Wang Y, Borchert ML, Deluca HF. Identification of the vitamin D receptor in various cells of the mouse kidney. Kidney Int, 2012, 81 : 993-1001.
  • 8Yang L, Ma J, Zhang X, et al. Protective role of the vitamin D receptor. Cell Immunol, 2012, 279 : 160-166.
  • 9Chow EC, Sun H, Khan AA, et al. Effects of l alpha, 25- dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo. Biopharm Drug Dispos, 2010, 31 : 91-108.
  • 10Zella LA, Kim S, Shevde NK, et al. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol Endocrinol, 2006, 20 : 1231 -1247.

共引文献3

同被引文献42

引证文献4

二级引证文献17

医学综述
2015年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部